tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Eric Criscuolo, 18 are a HOLD (47.37%), 1 are a SELL (2.63%), 19 are a BUY (50%).
Analyst Eric Criscuolo, currently employed carries an average stock price target met ratio of 78.13% that have a potential upside of 16.64% achieved within 145 days. Previously, Eric Criscuolo worked at MIZUHO.
Eric Criscuolo’s has documented 62 price targets and ratings displayed on 8 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CLVS, Clovis Oncology at 24-Aug-2016.
Analyst best performing recommendations are on XON (PRECIGEN).
The best stock recommendation documented was for EXAS (EXACT SCIENCES) at 5/4/2016. The price target of $12 was fulfilled within 57 days with a profit of $6.19 (106.54%) receiving and performance score of 18.69.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$75
$22.09 (41.75%)
$85
14 days ago
(11-Nov-2024)
4/9 (44.44%)
$23.67 (46.11%)
31
Buy
$65
$12.09 (22.85%)
$67
19 days ago
(06-Nov-2024)
10/12 (83.33%)
$14.51 (28.74%)
151
Buy
$67
$14.09 (26.63%)
$75
19 days ago
(06-Nov-2024)
9/10 (90%)
$16.51 (32.70%)
77
Buy
$65
$12.09 (22.85%)
$75
19 days ago
(06-Nov-2024)
0/5 (0%)
$14.51 (28.74%)
Buy
$75
$22.09 (41.75%)
$95
19 days ago
(06-Nov-2024)
2/11 (18.18%)
$24.51 (48.54%)
39
What Year was the first public recommendation made by Eric Criscuolo?
